FRI0609 USEFULNESS OF FDG-PET/CT IMAGING AND SEROLOGICAL

BIOMARKERS TO PREDICT RELAPSE IN IGG4-RELATED DISEASE
M. Kato, H. Ozaki, T. Kameda, M. Izumikawa, S. Nakashima, H. Shimada, R. Wakiya, A. Kondo, N. Kadowaki, H. Dobashi. Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kita-gun, Japan Background: IgG4-RD shows relapses frequently. It is important to search to the factors to predict relapse. Recent research has shown the usefulness of FDG-PET/CT for IgG4-RD because it is more sensitive than conventional imaging to detect organ involvement of the disease. It has been suggested that FDG-PET/CT is also useful for monitoring therapeutic response of IgG4-RD. Objectives: We investigate the usefulness of FDG-PET/CT imaging and serological biomarkers to predict relapse in IgG4-RD. Methods: We analyzed 24 patients with IgG4-RD treated for more than 1 year between 2008 and 2016 in our facility. The diagnosis for IgG4-RD was based on comprehensive diagnostic criteria for IgG4-RD. All cases underwent FDG-PET/CT at least once, and laboratory data were collected from their medical records retrospectively. Levels of serum C-reactive protein (CRP), eosinophil/leukocyte ratio, serum IgG, IgG4, IgA, IgM, IgE, sIL2-R and serum compliment were investigated. Results: The patients had a mean age of 67.9 years (range: 50-87 years). In the cases with high FDG uptake on FDG-PET/CT, they had a greater number of organ involvements, higher serum IgG and sIL-2R levels. Eight patients experienced relapses following treatment. Higher serum IgG predicted relapses of IgG4-RD. FDG-PET/CT findings at baseline were not associated with relapse. FDG-PET/CT was performed in 13 patients after initiation of treatment and 4 patients had a relapse. There were no significant reduction of abnormal FDG uptake in 6 patients, and 4 of 6 patients relapsed. Conclusions: In this study, we examined the factors to predict relapse in IgG4-RD. Patients with higher serum IgG were regarded as a risk of relapse, but FDG-PET/CT findings at baseline were not associated with relapse. FDG-PET/CT reexamined after initiation of treatment is useful to predict relapse of IgG4-RD. Background: The diagnosis of FMF (Familial Mediterranean Fever) can be missed or delayed even in a country like Turkey, one of the most prevalent places for FMF (1). Objectives: We compared the duration of delay in diagnosis before and after year 2000, and assessed the problems related with the diagnosis of FMF. Methods: We studied 143 (102 F, 41 M) consecutive patients with FMF seen at the rheumatology outpatient clinic, between November 2016 and January 2017. Patients completed a self-administered questionnaire that assesses initial symptoms, previous diagnosis and treatments received before the formal diagnosis of FMF. Patients were divided in 2: as Group 1, which includes 70 patients seen for the first time by a physician before 2000 and Group 2, which includes 73 patients seen after 2000. Results: The median age of the patients was 34 years . The F/M ratio was 2.4. The initial symptom was abdominal pain in the majority (n=134, 89%), followed by fever (n=114, 75%), arthritis (n=66, 44%), pleuritic pain (n=21, 14%), arthralgia (n=11, 7%) and other complaints (n=14, 9%). The median age at initial symptom was 10 years (IQR:6-23). The median delay in diagnosis was 8 years . This was significantly shorter in Group 2 (median: 4 years [IQR:0-11]) than that observed in Group 1 (median: 10 years [IQR:6-17]), as shown in Table. A total of 110 patients (73%) were diagnosed with one or more diseases or syndromes other than FMF. These were appendicitis (n=50, 45%), gastrointestinal diseases (n=44, 40%), acute rheumatic fever (n=36, 33%), inflammatory arthritis (n=18, 16%), gynecological diseases (n=11, 10%) kidney stones (n=9, 8%) and others (n=34, 31%). As shown in Table, the frequency of patients with misdiagnosis, was significantly lower in Group 2 (66%) compared to Group 1 (84%). A total of 59 patients (39%) received other long-term treatments, mainly monthly penicillin (n=28), prior to colchicine. There were 41 surgical interventions in 36 patients (24%), before the diagnosis of FMF, the most common being appendectomy in 31, gyneacological operations in 5, cholecystectomy in 3 and others in 2 occasions. It was noted that, the frequency of surgical operations was significantly decreased in Group 2 (12%) compared to Group 1 (27%) (Table) . The presence or absence of MEFV mutations was assessed in 69 patients (46%) before the diagnosis or after to reinforce the diagnosis. As expected, this was significantly more frequent in Group 2 (59%) compared to Group 1 (33%) ( Table) . Seventy patients (46%) were diagnosed as FMF only after someone else in the family (n=44) or a friend (n=26) had a similar diagnosis. The frequency of these patients was similar when Group 1 and 2 were compared.
Conclusions:
Although there is considerable decrease in delayed diagnosis of FMF, there is still significant amount of misdiagnoses after the year 2000, even in a geography where FMF is highly prevalent. General clinical examination and lab tests (serum levels of α1-antitrypsin, amylase, lipase, ferritin, creatine phosphokinase (CPK), rheumatoid factor) (RF), ANF, anti-DNA, ANCA), bacteriological and serological tests, radiological examination (chest CT scan), ultrasound examinations of skin and subcutaneous fat (SF) around the nodules, tuberculin skin test and histopathology of nodular skin samples were performed at baseline. Patients were re-tested during the follow up (FUP) when necessary. Results: Female middle-aged patients prevailed in the study group with the disease duration from 1 week to 25 years. Saucer -like depressions as a Pnspecific phenomenon was documented in 28,5% cases. The estimated risk of saucer -like depressions was higher in patients who manifested Pn at the age of >40 years (OR 4, 9, 95% CI 2, (3) (4) (5) (6) (7) (8) (9) (10) 4; p<0, 0001) ; this subgroup also showed lesion proneness to confluence and forming of irregular shape conglomerates (OR 2,9, 95% CI 1, 45-5,7; p=0,002) , tendency to forming large size >3 cm lesions (OR 4, 96, 95% CI 2, (2) (3) (4) (5) (6) (7) (8) (9) (10) 97; p<0, 0001) , and the disease lasting over 3 months (OR 24, 9, 95% CI 9, 4; p<0, 0001) . All pts were re-examined within 1-6 years. Median time to onset of nodules regression was 2 [1;6] months. Recurrences were documented in 66 (35,5%) pts during the follow up. Logistic regression was used for multivariate statistical analysis in order to identify the potential predictors of delayed (>3 months) nodules regression and recurrence risk factors. Used model identified the following predictors of delayed nodules regression (i.e., disease regression): age >40 years (OR 2,58; CI 1,02-6,5; p=0,04), and presence of saucer-like depressions (OR 5,05; CI 1,2-21,7; p=0,03). The sensitivity of used statistical model was 70%, specificity -71%, positive predictive value -74%. Disease duration >3 months (OR 4, 7; CI 2, (0) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) 6; p=0, 0002) was identified by our model as the predictor of recurrences with 60% sensitivity, 78% specificity, and 59% positive predictive value. Conclusions: Pn tends to regress more slowly in pts aged over 40 and in pts having saucer-like depressions. Trend to recurrences is not so evident in Pn, although probability of recurrence increases in pts with longer disease duration at the time of initiation of therapy. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.3850
